Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Odyssey Therapeutics, Inc. (ODTX) had Return on Tangible Equity of -12.97% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-52.79M |
|
-- |
|
-- |
|
$55.47M |
|
$-55.47M |
|
$2.67M |
|
$-52.80M |
|
$-52.80M |
|
$-52.79M |
|
$-52.79M |
|
$-52.79M |
|
$-52.79M |
|
$-55.47M |
|
$-54.43M |
|
30.28M |
|
30.28M |
|
$-1.74 |
|
$-1.74 |
|
| Balance Sheet Financials | |
$321.46M |
|
$4.88M |
|
$162.39M |
|
$483.85M |
|
$28.30M |
|
-- |
|
$34.33M |
|
$62.63M |
|
$421.22M |
|
$407.04M |
|
$421.22M |
|
47.89M |
|
| Cash Flow Statement Financials | |
$-75.54M |
|
$-176.64M |
|
$292.64M |
|
$44.90M |
|
$85.48M |
|
$40.59M |
|
$8.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-75.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.53% |
|
|
Return on Tangible Equity |
-12.97% |
-10.91% |
|
-12.53% |
|
$8.80 |
|
$-2.50 |
|
$-2.50 |
|